Ghosheh Faris R, Cremona Federico, Ayres Brandon D, Hammersmith Kristin M, Cohen Elisabeth J, Raber Irving M, Laibson Peter R, Rapuano Christopher J
Cornea Service, Wills Eye Institute, Philadelphia, PA 19107, USA.
Eye Contact Lens. 2008 Jul;34(4):211-4. doi: 10.1097/ICL.0b013e31816212d2.
To identify current indications and trends in indications for penetrating keratoplasty (PKP) and associated procedures.
Retrospective chart review of all patients who underwent PKP at Wills Eye Institute from January 1, 2001, to December 31, 2005.
A total of 1,162 cases were performed in this 5-year period. Leading indications for PKP were pseudophakic corneal edema (PCE) in 330 (28.4%) cases, followed by regraft in 250 (22.0%), keratoconus in 186 (16%), and Fuchs' endothelial dystrophy in 126 (10.8%) cases. Of the 330 cases of PCE, 232 (70.3%) were associated with posterior chamber intraocular lenses (PCIOLs) and 96 (29.1%) with anterior chamber lenses. In 330 eyes with PCE, the lens was not exchanged in 246 (74.5%) cases and was exchanged in 76 (23%) cases. Seventy of the exchanged lenses were anterior chamber intraocular lenses (ACIOLs) and six lenses were PCIOLs. In cases of ACIOL exchanges, 10 were for scleral sutured IOLs, 18 for PCIOLS, and 42 for another ACIOL.
Pseudophakic corneal edema remains the leading indication for PKP at our institution followed by regraft, continuing a trend noted in our previous studies. Although the percentage of cases of PCE associated with PCIOLS increased, fewer lenses were exchanged, perhaps reflecting increased confidence in biocompatibility of newer IOLs. The decrease in overall number of corneal transplants in these 5 years continues a trend noted in our previous study and mirrors the national decline in PKP.
确定穿透性角膜移植术(PKP)及其相关手术当前的适应证和适应证趋势。
对2001年1月1日至2005年12月31日在威尔斯眼科研究所接受PKP的所有患者进行回顾性病历审查。
在这5年期间共进行了1162例手术。PKP的主要适应证为假晶状体性角膜水肿(PCE),共330例(28.4%),其次是再次移植,共250例(22.0%),圆锥角膜186例(16%),Fuchs内皮营养不良126例(10.8%)。在330例PCE病例中,232例(70.3%)与后房型人工晶状体(PCIOL)相关,96例(29.1%)与前房型人工晶状体相关。在330只患有PCE的眼中,246例(74.5%)未更换晶状体,76例(23%)更换了晶状体。更换的晶状体中,70只为前房型人工晶状体(ACIOL),6只为PCIOL。在ACIOL更换病例中,10只为巩膜缝合人工晶状体,18只为PCIOL,42只为另一种ACIOL。
在我们机构,假晶状体性角膜水肿仍然是PKP的主要适应证,其次是再次移植,延续了我们之前研究中发现的趋势。尽管与PCIOL相关的PCE病例百分比有所增加,但更换的晶状体数量减少,这可能反映出对新型人工晶状体生物相容性的信心增强。这5年角膜移植总数的下降延续了我们之前研究中发现的趋势,也反映了全国PKP手术数量的下降。